Sudarshan Pharma Industries Limited (BOM:543828)

BOM:543828 Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	7,803	7,031	5,050	4,635	4,613	3,571
Revenue Growth	31.72%	39.21%	8.95%	0.48%	29.19%	84.52%
Gross Profit Gross Profit Growth	1,087	834.87	651.92	409.86	303.72	217.06
Operating Income Operating Income Growth	637.42	484.87	373.5	224.48	143.12	101.5
Net Income Net Income Growth	290.26	233.03	149.3	114.55	70.37	52.48
Earnings Per Share EPS Growth	1.20	0.97	0.62	0.48	0.29	0.36
EPS Growth	52.34%	56.18%	29.17%	64.16%	-19.65%	108.19%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	7,585	6,812	4,495	4,635	4,613	3,571
outside India outside India Growth	-	218.5	554.86	-	-	-
Total Total Growth	7,803	7,031	5,050	4,635	4,613	3,571

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	11.74	11.35	22.2	16.44	117.19	2.36
Total Debt Total Debt Growth	3,919	2,850	1,746	1,048	341.04	305.92
Net Cash (Debt) Net Cash Growth	-3,908	-2,839	-1,724	-1,032	-223.85	-303.56
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-16.00	-11.66	-7.12	-4.32	-0.93	-2.11

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-660.58	-22.99	-323.24	96.86	-287.93	-38.22
Capital Expenditures CapEx Growth	-489.29	-690.97	-212.45	-37.84	-143.27	-16.56
Free Cash Flow Free Cash Flow Growth	-1,150	-713.96	-535.69	59.02	-431.2	-54.79
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	13.93%	11.88%	12.91%	8.84%	6.58%	6.08%
Operating Margin	8.17%	6.90%	7.40%	4.84%	3.10%	2.84%
Pretax Margin	5.02%	4.34%	3.96%	3.29%	2.06%	2.00%
Profit Margin	3.72%	3.31%	2.96%	2.47%	1.52%	1.47%
FCF Margin	-14.74%	-10.15%	-10.61%	1.27%	-9.35%	-1.53%

Dividends

Chart

Fiscal Year	FY 2023
Period Ending	Mar 31, 2023
Dividend Per Share Dividend Per Share Growth	0.030
Dividend Per Share Growth	-
Dividend Yield	0.75%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	26.55	25.03	49.23	15.57	13.64	-
P/FCF Ratio	-	-	-	30.22	-	-
PS Ratio	1.04	0.83	1.46	0.39	0.21	-

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error